Tag: FAS Russia

Federal Antimonopoly Service (the FAS Russia) is an authorized federal executive body, which is carrying out its functions with regard to the approval of the regulatory legal acts and control over compliance with the antimonopoly legislation, legislation in the field of natural monopolies’ activity, in the field of state regulation of prices (tariffs) for the goods (services), advertising, foreign investments in the business entities of strategic importance for the Russian national defence and state security, control in the field of state defence order, purchases of goods, works and services for the state and municipal needs and procurement of goods, works and services by certain legal entities, as well as with regard to the approval of closed methods for selection of suppliers (contractors, performers).

AstraZeneca cut prices for socially important drugs in Russia by 12-92%

fas russia
The maximum ex-works prices for 11 trade names (8 INNs) of vital and essential drugs have been reduced within a short period of time. This price reduction ranged from 12 to 92 percent.

Relations of pharma companies with medical specialists should be regulated

nizhegorodcev fas russia
Timofey Nizhegorodtsev, the Head of the Department for Control over Social Sphere and Trade of Federal Antimonopoly Service (FAS) of Russia, spoke about the competition in the pharmaceutical market.

FAS Russia managed to reduce prices for Biperiden medicines

drug licensing
The Ninth Arbitration Court of Appeal confirmed the decision of the first instance court to invalidate the decisions of the Federal Tariff Service of Russia adopted in 2010 on approval of maximum ex-works prices for Akineton.

Russia may enact its register of interchangeable medicines from January 1, 2019

drugs
Russian Ministry of Health completed its work on the bill to amend the Federal Law “On Circulation of Medicines” which provides, in particular, for the establishment of a register of interchangeable drugs.

FAS will inspect large pharmaceutical companies once in 5 years

manufacturing
The Russian Government signed a Decree that approved the criteria for assigning specific risk categories to legal entities and individual entrepreneurs.

SPICs should involve the transfer of unique technologies

fas russia
“Special Investment Contract cannot provide guarantees for the implementation of unfair activities,” said Timofey Nizhegorodtsev, the Head of the Department for Control over Social Sphere and Trade of FAS of Russia.

FAS of Russia identified unjustified 35% overpricing of Tyverb

FAS Russia
In April 2017, the FAS Russia initiated a case on the grounds that Novartis Pharma had violated Clause 1 of Part 1 of Article 10 of the Law on Protection of Competition

FAS will support Russian manufacturers in the registration of prices

artemjev
The head of Federal Antimonopoly Service of Russia Igor Artemyev met with the executives of Pharmstandard PJSC and BIOCAD CJSC

FAS Russia reports on the most frequent violations in healthcare sector

drugs
The Federal Antimonopoly Service of Russia participates in the reform of control and oversight activities

Russian Court restricts the authority of FAS for interchangeability of drugs

pills-in-blisters
Today, the procurement of drugs is regulated by the Federal Law FZ-44, under which the state customer has the right to specify INN of the drug and other "product characteristics" in the description of the lot

Russia and BRICS countries will oppose the transnational pharmaceutical companies

artemyev
Russia, together with other BRICS countries, will take measures against transnational drug manufacturers involved in bribing the doctors and selling expired medicines

FAS of Russia advocates the “third wheel” rule transformation

documents
Igor Artemyev, the Head of the Federal Antimonopoly Service of Russia, spoke about his agency's position on the current use of “third wheel” rule in public procurement of drugs

Russia may authorize compulsory licensing of medicinal products this year

artemyev
The procedure for compulsory licensing of drugs may be introduced in Russia as early as this year, said Igor Artemyev, the Head of the Federal Antimonopoly Service.

“Percentage” preferences will provide incentives to localize manufacturing

manufacturing
Rachik Petrosyan, the Deputy Head of the Russian Antimonopoly Service (FAS), said that his agency views the presence of foreign suppliers as a tremendous benefit for the Russian market

Reduction of prices on VED in Russia will save more than 5 billion rubles

medvedev-artemiev
Igor Artemyev, the Head of the Federal Antimonopoly Service, informed Dmitry Medvedev, the Chairman of the Government of the Russian Federation, on the results of measures taken to reduce the prices of vital and essential drugs

B. Brown Medical is suspected to be involved in cartel agreement

fas russia
The Federal Antimonopoly Service (FAS) of Russia is suspecting the Russian subsidiary of B. Braun Medical, a German company, to be involved in one of the largest cartel agreements in the sale of medicines